NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹773 Cr | ₹674 Cr | ₹493 Cr | ₹322 Cr | ₹218 Cr |
What is the latest Net Current Assets ratio of NEULAND LABORATORIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹773 Cr |
| Mar2025 | ₹674 Cr |
| Mar2024 | ₹493 Cr |
| Mar2023 | ₹322 Cr |
| Mar2022 | ₹218 Cr |
How is Net Current Assets of NEULAND LABORATORIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹773 Cr | 14.71 | |
| Mar2025 | ₹674 Cr | 36.57 | |
| Mar2024 | ₹493 Cr | 53.26 | |
| Mar2023 | ₹322 Cr | 47.92 | |
| Mar2022 | ₹218 Cr | - | |
Compare Net Current Assets of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹26,773.2 Cr | 6.2% | 2.8% | 13.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 6.2% |
2.8% |
13.4% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses